Breaking News Instant updates and real-time market news.

WOW

WideOpenWest

$9.20

0.07 (0.77%)

, SIEN

Sientra

$10.38

0.07 (0.68%)

12:41
03/13/18
03/13
12:41
03/13/18
12:41

Notable companies reporting after market close

Notable companies reporting after the market close, with earnings consensus, include WideOpenWest (WOW), consensus 28c... Sientra (SIEN), consensus (70c)... PetIQ (PETQ), consensus 8c... Natera (NTRA), consensus (47c)... Inter Parfums (IPAR), consensus 11c.

WOW

WideOpenWest

$9.20

0.07 (0.77%)

SIEN

Sientra

$10.38

0.07 (0.68%)

PETQ

PetIQ

$22.93

0.24 (1.06%)

NTRA

Natera

$9.24

-0.05 (-0.54%)

IPAR

Inter Parfums

$47.75

0.75 (1.60%)

  • 13

    Mar

  • 13

    Mar

  • 13

    Mar

  • 14

    Mar

  • 14

    Mar

WOW WideOpenWest
$9.20

0.07 (0.77%)

11/14/17
RHCO
11/14/17
NO CHANGE
Target $18
RHCO
Buy
WideOpenWest price target lowered to $18 from $24 at SunTrust
SunTrust analyst Greg Miller lowered his price target on WideOpenWest to $18 following Q3 earnings miss, saying tighter competition and the impact from Hurricane Irma drove the shortfall. The analyst says that while the company's pending fiber network sale improves liquidity and supports Edge-Out penetration growth, competition from Charter's (CHTR) Spectrum and AT&T's (T) DirecTV offers exacerbate the decline. Miller maintains a Buy rating on the stock.
06/19/17
06/19/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Qualcomm (QCOM) reinstated with a Hold at Deutsche Bank. 2. WideOpenWest (WOW) was initiated with an Outperform at Macquarie, RBC Capital, Credit Suisse, and Evercore ISI, a Strong Buy at Raymond James, as well as a Buy at SunTrust and UBS. 3. Appian (APPN) was initiated with an Outperform at Cowen, an Equal Weight at Morgan Stanley and Barclays, a Sector Weight at Pacific Crest, a Hold at Canaccord, and a Neutral at Goldman Sachs. 4. Smart Global (SGH) was initiated with an Overweight at Barclays, a Strong Buy at Needham, and a Buy at Roth Capital, Stifel, Jefferies, and Deutsche Bank. 5. Credit Suisse (CS) resumed with a Buy at BofA/Merrill. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
06/19/17
MACQ
06/19/17
INITIATION
Target $20
MACQ
Outperform
WideOpenWest initiated with an Outperform at Macquarie
Macquarie analyst Amy Yong initiated WideOpenWest with an Outperform and a $20 price target citing edge-out opportunities and a deleveraging balance sheet.
06/19/17
RBCM
06/19/17
INITIATION
RBCM
Outperform
WideOpenWest initiated with an Outperform at RBC Capital
RBC Capital analyst Jonathan Atkin started coverage of WideOpenWest with a $20 price target and an Outperform rating. The analyst says that WideOpenWest's "hyper-local focus in less competitive markets will enable the company to execute profitable network extensions, driving top-line and margin growth." The analyst adds that it should benefit from its "video agnostic" approach which enables it to target viewers of all types of video.
SIEN Sientra
$10.38

0.07 (0.68%)

09/13/17
WBLR
09/13/17
UPGRADE
WBLR
Outperform
Sientra upgraded to Outperform from Market Perform at William Blair
William Blair analyst Margaret Kaczor upgraded Sientra to Outperform saying the manufacturing approval is "just the tip of the story."
01/19/18
STFL
01/19/18
UPGRADE
STFL
Buy
Sientra upgraded to Buy from Hold at Stifel
01/19/18
01/19/18
UPGRADE
Target $14

Buy
Sientra upgraded to Buy at Stifel
As previously reported, Stifel analyst Johnathan Block upgraded Sientra to Buy from Hold, stating that his September checks showed likely market share gains upon full resumption of manufacturing. Doctor feedback from miraDry users indicate that results appear efficacious and patient volumes are expected to increase, Block added. The analyst, who also pointed to easy year-ago comps in the second half for both of the company's businesses, set a $14 price target on Sientra shares. However, he did note that the upgrade may be coming before Sientra may end up raising additional capital in the near-term.
02/21/18
LSCM
02/21/18
DOWNGRADE
Target $11
LSCM
Hold
Sientra downgraded to Hold from Buy at Lake Street
Lake Street analyst Brooks O'Neil downgraded Sientra to Hold and lowered his price target for the shares to $11 from $15. The company is "attempting to walk a fine line" with the at-the-market equity offering announced last night, O'Neil tells investors in a research note. The analyst does not sense there is a new delay related to securing FDA approval for silicone breast implant manufacturing with Vesta, but thinks near-term cash consumption, execution, and dilution risks may act as an overhang on the stock.
PETQ PetIQ
$22.93

0.24 (1.06%)

08/15/17
RHCO
08/15/17
INITIATION
Target $28
RHCO
Buy
PetIQ initiated with a Buy at SunTrust
SunTrust analyst William Chappell started PetIQ with a Buy rating and $28 price target. Increased customer penetration should drive "strong" growth over the next few years, the analyst contends.
08/15/17
RAJA
08/15/17
INITIATION
Target $26
RAJA
Outperform
PetIQ initiated with an Outperform at Raymond James
Raymond James analyst Joseph Altobello initiated PetIQ with an Outperform and a $26 price target saying the company is poised for double digit net sales and EBITDA growth.
08/15/17
08/15/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Kratos Defense (KTOS) initiated with a Buy at Drexel Hamilton. 2. PetIQ (PETQ) was initiated with an Outperform at Raymond James, William Blair, and Oppenheimer, while being initiated with a Buy at SunTrust and a Hold at Jefferies. 3. Donnelley Financial Solutions (DFIN) initiated with a Neutral at JPMorgan. 4. Calyxt (CLXT) initiated with a Buy at Citi. 5. Ecolab (ECL) initiated with an Equal Weight at Morgan Stanley. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
11/20/17
JEFF
11/20/17
UPGRADE
Target $26
JEFF
Buy
PetIQ upgraded to Buy from Hold at Jefferies
Jefferies analyst Kevin Grundy upgraded PetIQ to Buy saying the recent pullback in shares provides an attractive entry point. In a non-deal roadshow, management conveyed a "high degree of confidence" in the company's outlook, Grundy tells investors in a research note. He believes the short thesis that has emerged "brings little new" information.
NTRA Natera
$9.24

-0.05 (-0.54%)

07/14/17
PIPR
07/14/17
NO CHANGE
Target $18
PIPR
Overweight
Piper views updated Aetna policy as disappointing for Natera
Piper Jaffray analyst William Quirk views Aetna's (AET) updated non-invasive prenatal testing medical policy, where it decided to continue covering the test only in high risk, as "disappointing." Upside for Natera (NTRA) in the second half of 2017 now falls on Medicaid and microdeletion reimbursement progress, and less so commercial payers flipping to cover average risk, Quick tells investors in a research note. He keeps an Overweight rating on Natera shares with an $18 price target.
11/14/17
ADAM
11/14/17
NO CHANGE
Target $15
ADAM
Buy
Natera Q3 results strong, oncology update bullish, says Canaccord
Canaccord analyst Mark Massaro noted Natera reported strong Q3 results and showed signs of price stabilization and progress in cancer liquid biopsies. The analyst noted shares have been weak recently, which he believes is partially due to profit-taking following its gains over the past eight weeks. He lowered his estimates near-term due to uncertainty surrounding the timing of ACOG but said its progress on cancer liquid biopsies has led to eight contracts with pharma companies since launch in Q2. Massaro reiterated his Buy rating but lowered his price target to $15 from $16 on Natera shares.
01/02/18
PIPR
01/02/18
NO CHANGE
PIPR
Overweight
UnitedHealth update removes upside source for Natera, says Piper Jaffray
UnitedHealth (UNH) updated its non-invasive prenatal testing medical policy, continuing to only cover the test in high risk women, Piper Jaffray analyst William Quirk tells investors in a research note. The analyst says that while his estimates for Natera are unchanged, UnitedHealth's decision does remove one of the potential sources of 2018 upside for the shares. Aetna (AET) is the other large payer not covering average risk non-invasive prenatal testing, and an update from the insurer is likely in Mayor June, Quirk writes. He keeps an Overweight rating on Natera shares.
01/17/18
EAMC
01/17/18
INITIATION
Target $5
EAMC
Sell
Natera initiated with a Sell at Empire
Empire initiated Natera with a Sell and $5 price target.
IPAR Inter Parfums
$47.75

0.75 (1.60%)

02/26/18
BWSF
02/26/18
NO CHANGE
Target $56
BWSF
Buy
Inter Parfums licensing deal with Guess affirms bull case, says BWS Financial
BWS Financial analyst Hamed Khorsand said Inter Parfums' (IPAR) licensing deal with Guess (GES) came as somewhat of a surprise, noting that the latter has been using Coty (COTY) for fragrances since 2010. This deal affirms his bull case that Inter Parfums management is not complacent and is looking for growth opportunities, said Khorsand, who added that he believes the company is still looking for more transactions like its acquisition of Rochas. He keeps a Buy rating and $56 price target on Inter Parfums.
01/22/18
KEYB
01/22/18
DOWNGRADE
KEYB
Sector Weight
Inter Parfums downgraded to Sector Weight from Overweight at KeyBanc
KeyBanc analyst Jason Gere downgraded Inter Parfums to Sector Weight citing full valuation and lack of fundamental catalysts.
01/22/18
SBSH
01/22/18
DOWNGRADE
Target $52
SBSH
Neutral
Inter Parfums downgraded to Neutral from Buy at Citi
Citi analyst Wendy Nicholson downgraded Inter Parfums to Neutral citing valuation following the stock's recent rally. The analyst maintains a $52 price target for the shares, which she notes is based on the belief that Inter Parfums should trade at a 100% premium to the market.
01/11/18
DADA
01/11/18
UPGRADE
Target $51
DADA
Buy
Inter Parfums upgraded to Buy at DA Davidson on momentum in French unit
As reported earlier, DA Davidson analyst Linda Bolton Weiser upgraded Inter Parfums to Buy from Neutral and raised her price target to $51 from $46. Weiser cites the company's French unit, which accounts for over 80% of sales, boosting its FY17 revenue outlook by EUR15M on strong year-end momentum at the firm's main brands. The analyst says Inter Parfums may report an upside sales surprise with Q4 earnings on January 29th and also expects the strength in the Coach for Men brand to carry into the first half of 2018.

TODAY'S FREE FLY STORIES

NOK

Nokia

$5.89

-0.37 (-5.91%)

09:56
03/22/19
03/22
09:56
03/22/19
09:56
Options
Nokia option volume spikes as shares decline on compliance headlines »

Nokia option volume…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    May

VTR

Ventas

$64.28

0.56 (0.88%)

, CAG

Conagra Brands

$26.16

0.34 (1.32%)

09:55
03/22/19
03/22
09:55
03/22/19
09:55
Options
Early notable gainers among liquid option names on March 22nd »

Notable gainers among…

VTR

Ventas

$64.28

0.56 (0.88%)

CAG

Conagra Brands

$26.16

0.34 (1.32%)

EQR

Equity Residential

$74.88

0.6675 (0.90%)

HCP

HCP

$31.83

0.18 (0.57%)

ETR

Entergy

$95.63

0.75 (0.79%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Mar

  • 26

    Mar

  • 01

    May

09:55
03/22/19
03/22
09:55
03/22/19
09:55
General news
U.S. March Markit manufacturing PMI fell 0.5 ticks to 52.5 »

U.S. March Markit…

09:55
03/22/19
03/22
09:55
03/22/19
09:55
Conference/Events
UBS alternative energy analyst to hold an analyst/industry conference call »

Alternative Energy…

FITB

Fifth Third

$25.12

-0.31 (-1.22%)

09:52
03/22/19
03/22
09:52
03/22/19
09:52
Upgrade
Fifth Third rating change  »

Fifth Third upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Apr

  • 23

    Apr

CHGG

Chegg

$39.01

-0.645 (-1.63%)

09:52
03/22/19
03/22
09:52
03/22/19
09:52
Hot Stocks
Breaking Hot Stocks news story on Chegg »

Chegg drops 2% to $38.68…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CHGG

Chegg

$39.01

-0.645 (-1.63%)

09:51
03/22/19
03/22
09:51
03/22/19
09:51
Periodicals
Breaking Periodicals news story on Chegg »

Citron Research says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:50
03/22/19
03/22
09:50
03/22/19
09:50
Conference/Events
Stephens financial analysts to hold a luncheon meeting »

Analysts hold a…

09:50
03/22/19
03/22
09:50
03/22/19
09:50
Hot Stocks
Breaking Hot Stocks news story  »

Liberty TripAdvisor…

WSM

Williams-Sonoma

$59.48

0.26 (0.44%)

09:50
03/22/19
03/22
09:50
03/22/19
09:50
Options
In-the-money call buyers in Williams Sonoma at the opening bell »

In-the-money call buyers…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Apr

  • 03

    Apr

09:50
03/22/19
03/22
09:50
03/22/19
09:50
General news
U.S. existing home sales preview: »

U.S. existing home sales…

GTLS

Chart Industries

$94.49

(0.00%)

09:46
03/22/19
03/22
09:46
03/22/19
09:46
Recommendations
Chart Industries analyst commentary  »

Chart Industries'…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Apr

  • 28

    May

09:45
03/22/19
03/22
09:45
03/22/19
09:45
Hot Stocks
Breaking Hot Stocks news story  »

Liberty TripAdvisor…

09:45
03/22/19
03/22
09:45
03/22/19
09:45
General news
U.S. wholesale trade preview: »

U.S. wholesale trade…

09:45
03/22/19
03/22
09:45
03/22/19
09:45
General news
Wholesale Trade Inventories to be reported at 10:00 »

January Wholesale Trade…

09:45
03/22/19
03/22
09:45
03/22/19
09:45
General news
Existing Home Sales to be reported at 10:00 »

February Existing Home…

ZUO

Zuora

$24.34

(0.00%)

, NKE

Nike

$88.05

(0.00%)

09:40
03/22/19
03/22
09:40
03/22/19
09:40
Options
Unusually active option classes on open March 22nd »

Unusual total active…

ZUO

Zuora

$24.34

(0.00%)

NKE

Nike

$88.05

(0.00%)

TIF

Tiffany

$100.07

(0.00%)

NOK

Nokia

$6.26

(0.00%)

TME

Tencent Music

$17.44

(0.00%)

MRVL

Marvell

$20.80

(0.00%)

BBY

Best Buy

$70.56

(0.00%)

TWTR

Twitter

$32.61

(0.00%)

AAPL

Apple

$195.07

(0.00%)

PBR

Petrobras

$17.05

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Mar

  • 22

    Mar

  • 25

    Mar

  • 25

    Mar

  • 27

    Mar

  • 04

    Apr

  • 04

    Apr

  • 04

    Apr

  • 15

    Apr

  • 23

    Apr

  • 23

    Apr

  • 20

    May

MDT

Medtronic

$92.09

0.83 (0.91%)

09:37
03/22/19
03/22
09:37
03/22/19
09:37
Conference/Events
Medtronic management to meet with UBS »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Mar

  • 18

    May

  • 28

    May

LC

LendingClub

$3.00

0.065 (2.22%)

09:35
03/22/19
03/22
09:35
03/22/19
09:35
Conference/Events
LendingClub management to meet with UBS »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Mar

  • 01

    Apr

  • 02

    Apr

  • 28

    May

GVA

Granite Construction

$45.76

0.39 (0.86%)

09:34
03/22/19
03/22
09:34
03/22/19
09:34
Recommendations
Granite Construction analyst commentary  »

MKM Partners lowers…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Mar

PPC

Pilgrim's Pride

$21.32

0.71 (3.44%)

09:34
03/22/19
03/22
09:34
03/22/19
09:34
Hot Stocks
Pilgrim's Pride says Jayson Penn to succeed Bill Lovette as CEO »

Pilgrim's Pride…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

KR

Kroger

$24.33

0.35 (1.46%)

09:33
03/22/19
03/22
09:33
03/22/19
09:33
Conference/Events
Kroger management to meet with UBS »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Mar

EXPE

Expedia

$124.13

1.56 (1.27%)

09:30
03/22/19
03/22
09:30
03/22/19
09:30
Recommendations
Expedia analyst commentary  »

Expedia RNG trending in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:30
03/22/19
03/22
09:30
03/22/19
09:30
General news
U.S. Data Slate - Week of March 25: »

U.S. Data Slate - Week of…

09:30
03/22/19
03/22
09:30
03/22/19
09:30
General news
PMI Composite FLASH Manufacturing â€' Level to be reported at 09:45 »

March PMI Composite FLASH…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.